Search research articles
Contact Us
Filters
Showing results (31-40 of 187) with videos related to
Page
of 19
Sort By:
Micron (Oxford, England : 1993)
|
January 14, 2020
Biophysical changes caused by altered MUC13 expression in pancreatic cancer cells
Andrew E Massey, Kyle A Doxtater, Murali M Yallapu, et al.
Cells
|
August 29, 2020
miR-205: A Potential Biomedicine for Cancer Therapy
Neeraj Chauhan, Anupam Dhasmana, Meena Jaggi, et al.
The AAPS Journal
|
September 4, 2015
Therapeutic Applications of Curcumin Nanoformulations
Murali M Yallapu, Prashanth K Bhusetty Nagesh, Meena Jaggi, et al.
Biomedical Journal of Scientific & Technical Research
|
January 24, 2022
Molecular Modelling a Key Method for Potential Therapeutic Drug Discovery
Omar Karkoutly, Anupam Dhasmana, Vijian Dhevan, et al.
Nanotheranostics
|
June 26, 2025
Unveiling the potential of Urolithin A in Cancer Therapy: Mechanistic Insights to Future Perspectives of Nanomedicine
Vinita Karumuru, Anupam Dhasmana, Narsimha Mamidi, et al.
Current Opinion in Biotechnology
|
December 17, 2002
Pharmacokinetics and biodistribution of genetically engineered antibodies
Surinder K Batra, Maneesh Jain, Uwe A Wittel, et al.
Journal of Ovarian Research
|
December 15, 2012
Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
Mohd Saif Zaman, Diane M Maher, Sheema Khan, et al.
Molecular Cancer Research : MCR
|
April 1, 2011
Mucin 13: structure, function, and potential roles in cancer pathogenesis
Diane M Maher, Brij K Gupta, Satoshi Nagata, et al.
International Journal of Nanomedicine
|
December 1, 2011
Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes
Murali Mohan Yallapu, Mara C Ebeling, Neeraj Chauhan, et al.
Journal of Nature and Science
|
June 16, 2017
miR-145: Revival of a Dragon in Pancreatic Cancer
Saini Setua, Sheema Khan, Kyle Doxtater, et al.
Page
of 19
Search research articles
Search
Showing results (31-40 of 187) with videos related to
Sort By:
Page
of 19
Micron (Oxford, England : 1993)
|
January 14, 2020
Biophysical changes caused by altered MUC13 expression in pancreatic cancer cells
Andrew E Massey, Kyle A Doxtater, Murali M Yallapu, et al.
Cells
|
August 29, 2020
miR-205: A Potential Biomedicine for Cancer Therapy
Neeraj Chauhan, Anupam Dhasmana, Meena Jaggi, et al.
The AAPS Journal
|
September 4, 2015
Therapeutic Applications of Curcumin Nanoformulations
Murali M Yallapu, Prashanth K Bhusetty Nagesh, Meena Jaggi, et al.
Biomedical Journal of Scientific & Technical Research
|
January 24, 2022
Molecular Modelling a Key Method for Potential Therapeutic Drug Discovery
Omar Karkoutly, Anupam Dhasmana, Vijian Dhevan, et al.
Nanotheranostics
|
June 26, 2025
Unveiling the potential of Urolithin A in Cancer Therapy: Mechanistic Insights to Future Perspectives of Nanomedicine
Vinita Karumuru, Anupam Dhasmana, Narsimha Mamidi, et al.
Current Opinion in Biotechnology
|
December 17, 2002
Pharmacokinetics and biodistribution of genetically engineered antibodies
Surinder K Batra, Maneesh Jain, Uwe A Wittel, et al.
Journal of Ovarian Research
|
December 15, 2012
Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
Mohd Saif Zaman, Diane M Maher, Sheema Khan, et al.
Molecular Cancer Research : MCR
|
April 1, 2011
Mucin 13: structure, function, and potential roles in cancer pathogenesis
Diane M Maher, Brij K Gupta, Satoshi Nagata, et al.
International Journal of Nanomedicine
|
December 1, 2011
Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes
Murali Mohan Yallapu, Mara C Ebeling, Neeraj Chauhan, et al.
Journal of Nature and Science
|
June 16, 2017
miR-145: Revival of a Dragon in Pancreatic Cancer
Saini Setua, Sheema Khan, Kyle Doxtater, et al.
Page
of 19